[ad_1] NEW YORK, Aug. 23, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021 and May 14, 2024, […]
Tag: P. A.
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit
[ad_1] NEW YORK, Aug. 23, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023 and April 30, 2024, […]
CRWD Investors Have Opportunity to Lead CrowdStrike Holdings, Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, Aug. 23, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) between November 29, 2023 and […]
CXM Investors Have Opportunity to Lead Sprinklr, Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, Aug. 23, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June 5, 2024, both […]
STLA Investors Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit
[ad_1] NEW YORK, Aug. 21, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Stellantis N.V. (NYSE: […]
